对侧膝滑液生物标志物可预测膝关节损伤术后长期患者报告结局
本研究回顾性纳入32例接受膝关节镜手术且随访≥8年的患者,检测双侧膝关节滑液中10种促炎与抗炎生物标志物。发现对侧未受伤膝的滑液生物标志物水平可预测术侧膝长期患者报告结局,促炎标志物升高预测结局更差,抗炎标志物升高预测结局更好。
要点
- 对侧膝抗炎TIMP-1升高与长期VAS疼痛评分改善和KOOS-PS改善相关。
- 对侧膝促炎MMP-3和RANTES升高与长期KOOS-PS更差相关。
- 对侧膝IL-1Ra升高与长期VAS疼痛、Lysholm和Tegner评分更差相关。
核心结论
- 关节镜手术时对侧未受伤膝的滑液生物标志物水平可预测术侧膝的长期结局。
- 促炎生物标志物水平升高预测结局更差,抗炎细胞因子预测评分改善。
- 单侧膝关节损伤可能引起更广泛的全身炎症反应,从而影响患者长期结局。
研究设计与样本
- 病例系列研究,证据等级4级。
- 回顾性分析纳入关节镜术前接受膝关节滑液抽吸且随访≥8年的患者。
- 从受伤膝和对侧健康膝抽吸滑液,定量10种促炎和抗炎生物标志物浓度。
- 采用逐步线性回归分析对数归一化对侧生物标志物浓度、年龄、体重指数、损伤类型和Outerbridge分级对患者报告结局的预测作用。
- 比较对侧膝与受伤膝的生物标志物浓度以评估相关性。
主要发现
- 共纳入32例患者,平均年龄49.6±12.3岁,随访10.0±1.4年。
- 对侧膝抗炎TIMP-1升高与长期随访VAS疼痛评分改善(P=.002)和KOOS-PS改善(P<.001)相关。
- 对侧膝促炎MMP-3升高(P=.004)和RANTES升高(P=.035)与KOOS-PS更差相关。
- 对侧膝IL-1Ra升高与最终随访VAS疼痛(P=.006)、Lysholm(P=.005)和Tegner(P=.006)评分更差相关。
- 对侧膝MCP-1、MIP-1β、VEGF和TIMP-1浓度与术侧膝水平相关,但浓度显著更低。
临床怎么用
- 对侧未受伤膝滑液生物标志物或可作为预测膝关节镜手术长期结局的参考。
- 促炎与抗炎生物标志物联合检测有助于识别长期结局较差的高风险患者。
局限性
- 回顾性病例系列研究,证据等级4级。
- 样本量较小(32例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inflammatory biomarkers in an injured knee have been shown to predict outcomes, yet the role of the subsequent systemic inflammatory response to injury remains poorly understood. PURPOSE: To investigate whether synovial fluid (SF) biomarkers from the contralateral uninjured knee could predict long-term patient-reported outcomes (PROs) for the operative knee in patients undergoing arthroscopic knee surgery. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: This retrospective analysis included patients undergoing knee SF aspiration before arthroscopy with ≥8 years of follow-up. SF was aspirated from both the injured and healthy contralateral knees, and concentrations of 10 pro- and anti-inflammatory biomarkers were quantified. Patients completed visual analog scale (VAS) for pain score, Lysholm, Tegner, and Knee injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS) surveys preoperatively and at the final follow-up. Stepwise linear regression was performed to identify the most significant predictor(s) of PRO scores utilizing log-normalized contralateral biomarker concentration, age, body mass index, injury type, and Outerbridge grade as covariates. Concentrations from the contralateral knee were also compared with the injured knee to assess for correlations. RESULTS: A total of 32 patients with a mean age 49.6 ± 12.3 years and follow-up of 10.0 ± 1.4 years were included. Elevated anti-inflammatory tissue inhibitor of metalloproteinase 1 (TIMP-1) in the contralateral knee was associated with improved VAS pain score (P = .002) and KOOS-PS (P < .001) at long-term follow-up. Increased levels of contralateral pro-inflammatory matrix metalloproteinase 3 (P = .004) and regulated on activation normal T cell expressed and secreted (P = .035) were associated with worse KOOS-PS, while elevated interleukin 1 receptor antagonist was associated with worse VAS pain (P = .006), Lysholm (P = .005), and Tegner (P = .006) score at the final follow-up. Contralateral concentrations of monocyte chemotactic protein 1, macrophage inflammatory protein 1β, vascular endothelial growth factor, and TIMP-1 were correlated with levels in the operative knee but at significantly lower concentrations. CONCLUSION: SF biomarker levels in the contralateral uninjured knee at the time of arthroscopy were predictive of long-term outcomes for the operative knee. Increased levels of pro-inflammatory biomarkers were predictive of worse outcomes, while anti-inflammatory cytokines predicted improved scores. These results suggest that unilateral knee injury can result in a broader systemic inflammatory response that influences long-term outcomes in patients.
引用
- Berzolla E, Sundaram V, Lezak BA, et al. Synovial Fluid Biomarkers in the Contralateral Knee Predict Patient-Reported Outcomes After Injury at Long-term Follow-up. Am J Sports Med. 2026. PMID: 41626727. doi:10.1177/03635465251401555
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。